Ten 
States, prevalence estimates from the second National Health and Nutrition Examination Survey (NHANES II) mdicated that 1-6% ofthe population has impaired iron status (2) . Numerous metabolic consequences of iron deficiency have been described (3) (4) (5) (6) (7) . In the rat model, poor thermoregulation is one of these deleterious consequences (8-1 1), with indications that thyroid-hormone metabolism and catecholamine metabolism are both significantly altered in iron deficiency (8-13).
One preliminary report in humans (14) showed that irondeficient-anemic subjects failed to thermoregulate normally during cold-water immersion, with a resultant significant loss of body temperature. Interpretation of that study was confounded by significantly lower body fat, as indicated by heightto-weight ratio, in iron-deficient-anemic compared with control subjects. Thus, the significantly greater metabolic rates and higher plasma norepinephrine concentrations in the anemic subjects could have been causally related to both their body fatness and their iron deficiency.
As 
Methods

Research design
This research was designed as a combined cross-sectional and longitudinal study using a pre-and posttreatment experimental design with oral iron supplementation as the treatment. Such a design allowed us to examine differences in thermoregulatory capacity between iron-deficient anemic (IDA), iron-depleted (IDP), and iron-sufficient control (C At the end ofthe warm-water baseline period, 5 #{176}C cold water and ice were added to the tank to mix with and replace the warm water and to quickly (10-1 5 mm) lower the temperature ofthe water bath to 28 #{176}C. A pump system circulated the cool water throughout the tank to ensure a uniform water temperature. The subject remained in this cool water for 100 mm. At the time the water reached 28 #{176}C (time 0) and at 20-mm intervals thereafter until 100 mm, a blood sample was drawn and core body temperature and respiratory-gas measurements were recorded.
Figure 1 presents a timeline overview of the waterbath data-collection procedure.
To facilitate the subject's ability to remain in the cool water for 100 mm, she was shown a movie on a videocassette recorder. 
Blood analyses
Statisticalanalvses
The general analytic scheme was a two-way repeated-measures analysis of variance (ANOVA) with iron group as the between-subject factor and supplementation status as the withinsubject factor. There were two to three replicate water baths for each subject at both pre-and postsupplementation.
We decided a priori to perform separate, cross-sectional analyses at the following three time points: baseline and 40 and 100 mm of cool- We had to reassign one subject with an initial Hb concentration > 120 g/L from the IDP to the IDA group because ofan increase of24 g/L in her Hb concentration after iron supplementation.
As expected from our screening criteria, there were no differences in percentage body fat, lean body weight, or body surface area among groups (Table  2 ). There were no significant differences among the groups with respect to the number of hours fasted before the water bath (means for each group ranged from 8.8 to 10.8 h) or day of the menstrual cycle (means ranging from day 5 to day 1 1). Plasma estrogen and progesterone measurements (data not shown) verified that water baths were performed while subjects were in the follicular phase ofthe menstrual cycle.
Exposure to 28 #{176}C water for 100 mm (Fig 2) VO2 ofthe three groups ofsubjects did not differ at baseline before iron supplementation (Fig 3) . The IDA subjects did have a significantly lower VO2 than did the C subjects at 100 mm and than the IDP subjects at both 40 and 100 mm of coolwater exposure. Figure 4 shows quite clearly that IDA subjects had significantly lower plasma T3 concentrations than did the C or IDP women throughout the water baths. These differences persisted even after iron supplementation despite a significant 12% rise in T3 concentration in the IDA group at baseline after iron therapy.
Women with depleted iron stores had significantly lower mean plasma T3 concentrations than did the C women at baseline and at 40 and 100 mm of cool water exposure after the supplementation period. As shown in Figure 5 , plasma T4 concentrations were also significantly lower in the IDA subjects than the C or IDP subjects throughout the water baths and were not normalized with 3 mo of iron supplementation. Before iron supplementation, the IDP women had a significantly greater mean TSH concentration than did the C women at baseline (data not shown). This difference was not evident at the 40-or 100-mm time points or after the iron-supplementation period. Plasma norepinephrine concentrations did not differ among VO2 ofIDA was significantly lower than C (P = 0.04) at 100 mm and than IDP at 40 (P = 0.002) and 100 (P = 0.02) mm, presupplementation.
There was a significant decrease in V02 ofIDP at baseline (-lO)(P = 0.01), 40 (P = 0.05), and l00(P = 0.03) mm after 12 wk ofiron supplementation. VO2 ofIDA significantly lower than C at baseline (P = 0.02), 40 (P = 0.03), and 100 (P = 0.006) mm, postsupplementation.
groups in either the cross-sectional comparisons or the longitudinal comparisons (Fig 6) . Similarly, by using log-transformed data to normalize the distributions, we found that plasma epinephrine concentrations were highly variable and generally were not different among groups (Fig 7) . 
